Cite
HARVARD Citation
Jones, R. et al. (2019). A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb‐004) in metastatic soft‐tissue sarcomas. Cancer. 125 (14), pp. 2445-2454. [Online].